Patent · US Active

Crystal form A of compound and preparation method thereof

US10392401B2 · kind B2 · utility

0Cited by

1References

9Claims

0Family size

Assignee

SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES · CN

Inventors

Hong Liu · Shanghai, CN
Jiang Wang · Shanghai, CN
Jian Li · Shanghai, CN
Jia-He Li · Cockeysville, US
Jingya Li · Gothenburg, SE
Shengbin Zhou · Shanghai, CN
Mingbo Su · Shanghai, CN
Hualiang Jiang · Shanghai, CN
Xiaomin Luo · Shanghai, CN
Kaixian Chen · Shanghai, CN

Key dates

Filing date	Feb 3, 2016
Grant date	Aug 27, 2019
Priority date	—
Expiry date	Feb 3, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to crystal form A of a compound. The present invention also discloses a preparation method and a pharmaceutical composition of the crystal form A. The crystal form A has strong hypoglycemic activity in vivo and is expected to be a novel pharmaceutically active ingredient for treating or preventing type II diabetes and/or complications of type II diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.